SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-18-003230
Filing Date
2018-03-21
Accepted
2018-03-21 07:00:22
Documents
1
Period of Report
2018-03-21

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k032118_biondvaxpharma.htm 6-K 12329
  Complete submission text file 0001213900-18-003230.txt   13319
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 18703266
SIC: 2836 Biological Products, (No Diagnostic Substances)